NOVOCART 3D

BIOLOGICAL4 trials

Sponsors

Aesculap Biologics, LLC, Tetec AG

Conditions

Articular Cartilage DefectArticular Cartilage of the Femoral Condyle Between 2-6cm2Cartilage DiseaseCartilage Diseases

Phase 3

NOVOCART®3D for Treatment of Articular Cartilage of the Knee

Active, not recruitingNCT01957722

Aesculap Biologics, LLCArticular Cartilage of the Femoral Condyle Between 2-6cm2

Start: 2013-12-31End: 2027-12-31Updated: 2025-03-21

NOVOCART 3D Treatment Following Microfracture Failure

Active, not recruitingNCT03219307

Aesculap Biologics, LLCArticular Cartilage Defect

Start: 2018-11-30End: 2029-01-31Target: 30Updated: 2025-03-21

Unknown Phase

Non-Interventional Study to Evaluate Safety and Efficacy of NOVOCART 3D in Patients With Cartilage Defects

CompletedNCT02348697

Tetec AGCartilage Diseases

Start: 2015-06-30End: 2019-10-30Updated: 2019-12-03

Non-interventional Study With NOVOCART® 3D for the Treatment of Cartilage Defects of the Knee in Pediatric Patients

Active, not recruitingNCT04186208

Tetec AGCartilage Disease

Start: 2017-04-25End: 2026-06-30Updated: 2025-05-14